Bedwetting remains one of the most underdiagnosed and undertreated conditions in pediatric medicine, yet its psychological toll — reduced self-esteem, social withdrawal, and family stress — can linger well into adolescence. A newly revised Chinese expert consensus now offers a comprehensive, evidence-informed framework that updates standards dormant since 2014, with implications for pediatricians, nephrologists, and primary care providers worldwide.
Developed by the Chinese Cooperative Group for the Management of Pediatric Nocturnal Enuresis using the Delphi method, the consensus engaged 42 multidisciplinary panelists who iteratively voted on statements until at least 90% agreement was reached, yielding 18 finalized recommendations. Diagnostic criteria were updated to define nocturnal enuresis as at least one involuntary nighttime void per month over three months in children aged five or older. A central organizational distinction separates monosymptomatic nocturnal enuresis — bedwetting without daytime urinary symptoms — from the nonmonosymptomatic form, which requires a more layered assessment including voiding diary analysis. First-line treatment is stratified by underlying mechanism: desmopressin is prioritized for children with documented nocturnal polyuria, while enuresis alarm therapy is recommended when reduced functional bladder capacity is the primary driver.
This consensus carries weight beyond its regional origins. The Delphi methodology with a 90% agreement threshold is methodologically rigorous, lending the recommendations credibility that many single-institution guidelines lack. Importantly, the stratified treatment approach — matching therapy to bladder physiology rather than applying a blanket protocol — aligns with evolving international guidance from the International Children's Continence Society. The practical limitation is that its evidence base is filtered through a predominantly Chinese clinical population, which may not fully generalize across ethnic or healthcare-system contexts. Still, the inclusion of strategies for treatment-resistant cases positions this document as incrementally meaningful, particularly for clinicians managing the estimated 5–10% of school-age children globally who experience persistent bedwetting. Overall, this is a confirmatory and consolidating contribution rather than a paradigm shift.